183 related articles for article (PubMed ID: 12727930)
41. Hormone secretion in vitro by plurihormonal pituitary adenomas of the acidophil cell line.
Asa SL; Kovacs K; Horvath E; Singer W; Smyth HS
J Clin Endocrinol Metab; 1992 Jul; 75(1):68-75. PubMed ID: 1352308
[TBL] [Abstract][Full Text] [Related]
42. Human growth hormone and prolactin secreting pituitary adenomas analyzed by in situ hybridization.
Lloyd RV; Cano M; Chandler WF; Barkan AL; Horvath E; Kovacs K
Am J Pathol; 1989 Mar; 134(3):605-13. PubMed ID: 2466405
[TBL] [Abstract][Full Text] [Related]
43. Expression of peroxisome proliferator-activated receptors (PPARs) in human urinary bladder carcinoma and growth inhibition by its agonists.
Yoshimura R; Matsuyama M; Segawa Y; Hase T; Mitsuhashi M; Tsuchida K; Wada S; Kawahito Y; Sano H; Nakatani T
Int J Cancer; 2003 May; 104(5):597-602. PubMed ID: 12594814
[TBL] [Abstract][Full Text] [Related]
44. Somatostatin receptor subtype 1 selective activation in human growth hormone (GH)- and prolactin (PRL)-secreting pituitary adenomas: effects on cell viability, GH, and PRL secretion.
Zatelli MC; Piccin D; Tagliati F; Ambrosio MR; Margutti A; Padovani R; Scanarini M; Culler MD; degli Uberti EC
J Clin Endocrinol Metab; 2003 Jun; 88(6):2797-802. PubMed ID: 12788890
[TBL] [Abstract][Full Text] [Related]
45. Gonadotropin-releasing hormone agonists are unsuccessful in reducing tumoral gonadotropin secretion in two patients with gonadotropin-secreting pituitary adenomas.
Sassolas G; Lejeune H; Trouillas J; Forest MG; Claustrat B; Lahlou N; Loras B
J Clin Endocrinol Metab; 1988 Jul; 67(1):180-5. PubMed ID: 2967850
[TBL] [Abstract][Full Text] [Related]
46. Recovery of hypopituitarism after neurosurgical treatment of pituitary adenomas.
Webb SM; Rigla M; Wägner A; Oliver B; Bartumeus F
J Clin Endocrinol Metab; 1999 Oct; 84(10):3696-700. PubMed ID: 10523016
[TBL] [Abstract][Full Text] [Related]
47. Prolactin (PRL)-releasing peptide stimulates PRL secretion from human fetal pituitary cultures and growth hormone release from cultured pituitary adenomas.
Rubinek T; Hadani M; Barkai G; Melmed S; Shimon I
J Clin Endocrinol Metab; 2001 Jun; 86(6):2826-30. PubMed ID: 11397894
[TBL] [Abstract][Full Text] [Related]
48. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.
Buurman H; Saeger W
Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024
[TBL] [Abstract][Full Text] [Related]
49. Recognition of gonadotroph adenomas in women.
Daneshdoost L; Gennarelli TA; Bashey HM; Savino PJ; Sergott RC; Bosley TM; Snyder PJ
N Engl J Med; 1991 Feb; 324(9):589-94. PubMed ID: 1899470
[TBL] [Abstract][Full Text] [Related]
50. Induction mechanism of apoptosis by troglitazone through peroxisome proliferator-activated receptor-gamma in gastric carcinoma cells.
Yoshida K; Tanabe K; Fujii D; Oue N; Yasui W; Toge T
Anticancer Res; 2003; 23(1A):267-73. PubMed ID: 12680223
[TBL] [Abstract][Full Text] [Related]
51. Therapeutic treatment of DMBA-induced mammary tumors with PPAR ligands.
Pighetti GM; Novosad W; Nicholson C; Hitt DC; Hansens C; Hollingsworth AB; Lerner ML; Brackett D; Lightfoot SA; Gimble JM
Anticancer Res; 2001; 21(2A):825-9. PubMed ID: 11396171
[TBL] [Abstract][Full Text] [Related]
52. [Effects of irradiation therapy and inhibiting drugs on the pituitary and its adenomas].
Saeger W
Pathologe; 2006 Feb; 27(1):57-60. PubMed ID: 16362259
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of Notch signaling attenuates pituitary adenoma growth in Nude mice.
Zubeldía-Brenner L; De Winne C; Perrone S; Rodríguez-Seguí SA; Willems C; Ornstein AM; Lacau-Mengido I; Vankelecom H; Cristina C; Becu-Villalobos D
Endocr Relat Cancer; 2019 Jan; 26(1):13-29. PubMed ID: 30121620
[TBL] [Abstract][Full Text] [Related]
54. Transplantation of human pituitary adenomas into nude mice.
Oosterom R; Verleun T; Uitterlinden P; Romijn JC; Lamberts SW
Horm Res; 1983; 17(1):57-64. PubMed ID: 6840673
[TBL] [Abstract][Full Text] [Related]
55. BRD4 as a therapeutic target for nonfunctioning and growth hormone pituitary adenoma.
Shi C; Ye Z; Han J; Ye X; Lu W; Ji C; Li Z; Ma Z; Zhang Q; Zhang Y; He W; Chen Z; Cao X; Shou X; Zhou X; Wang Y; Zhang Z; Li Y; Ye H; He M; Chen H; Cheng H; Sun J; Cai J; Huang C; Ye F; Luo C; Zhou B; Ding H; Zhao Y
Neuro Oncol; 2020 Aug; 22(8):1114-1125. PubMed ID: 32246150
[TBL] [Abstract][Full Text] [Related]
56. Induction of apoptosis in murine ACTH-secreting pituitary adenoma cells by bromocriptine.
Yin D; Kondo S; Takeuchi J; Morimura T
FEBS Lett; 1994 Feb; 339(1-2):73-5. PubMed ID: 7508871
[TBL] [Abstract][Full Text] [Related]
57. Attenuation of MAMLD1 Expression Suppresses the Growth and Migratory Properties of Gonadotroph Pituitary Adenomas.
Qi J; Ni W
Pathol Oncol Res; 2020 Apr; 26(2):937-946. PubMed ID: 30911995
[TBL] [Abstract][Full Text] [Related]
58. Experimental Evidence and Clinical Implications of Pituitary Adenoma Stem Cells.
Würth R; Thellung S; Corsaro A; Barbieri F; Florio T
Front Endocrinol (Lausanne); 2020; 11():54. PubMed ID: 32153500
[TBL] [Abstract][Full Text] [Related]
59. Therapeutic potential of thiazolidinediones as anticancer agents.
Panigrahy D; Shen LQ; Kieran MW; Kaipainen A
Expert Opin Investig Drugs; 2003 Dec; 12(12):1925-37. PubMed ID: 14640937
[TBL] [Abstract][Full Text] [Related]
60. Effects of anti-estrogens on cell invasion and survival in pituitary adenoma cells: A systematic study.
Hannen R; Steffani M; Voellger B; Carl B; Wang J; Bartsch JW; Nimsky C
J Steroid Biochem Mol Biol; 2019 Mar; 187():88-96. PubMed ID: 30439415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]